Dual diagnosis treatment for Lantana — one team, both diagnoses, together.

For Lantana and Hypoluxo Island residents, RECO Health is 18 minutes down Federal Highway — the closest clinically led PHP and IOP for co-occurring substance use and psychiatric disorders north of the Broward County line. Dual diagnosis at RECO means one in-house addiction psychiatrist manages buprenorphine, naltrexone, and psychotropic medication together, on the same treatment plan as trauma-informed therapy delivered by dually trained clinicians. That single-team model, with rTMS and ketamine available on campus for treatment-resistant depression, is why referring providers in central Palm Beach County send their most complex co-occurring cases here.

Lantana and Hypoluxo Island sit on a narrow strip of coast between Delray Beach and West Palm — close enough to A1A that the Atlantic is a two-minute walk from most of the older neighborhoods, and close enough to RECO Health’s Delray Beach campus that the drive is 11 miles and roughly 18 minutes down Federal Highway. For residents of Old Town Lantana, Manalapan, and Ocean Ridge, that geography matters: RECO is the closest clinically led PHP and IOP for co-occurring substance use and psychiatric disorders north of the Broward County line. What follows is a description of what integrated dual diagnosis treatment actually is, how it differs from the sequential model most people are handed elsewhere, and how the admissions pathway works from a Lantana address.

Why sequential treatment fails for co-occurring disorders

The sequential model — “get sober first, then we’ll address the mental health” — is one of the most durable myths in American addiction care, and the research is unambiguous that it produces worse outcomes than integrated treatment. When major depressive disorder is left untreated during the first weeks of abstinence, anhedonia and hopelessness drive early relapse before behavioral therapy has time to take hold. When active substance use is left untreated during a depression episode, SSRIs like sertraline or escitalopram fail to reach therapeutic effect, and the client and prescriber both conclude — incorrectly — that “the medication didn’t work.”

SAMHSA has designated integrated treatment as the standard of care for co-occurring disorders since the early 2000s, and the evidence base has only strengthened since. Integration is not simply a matter of a therapist “also asking about mood.” It requires clinicians dually trained in addiction and psychiatry, a shared treatment plan, and a single prescribing physician who understands both domains. RECO Health’s dual diagnosis program is built on that model rather than layered on top of a substance-use-only curriculum.

The high-prevalence co-occurring diagnoses

Five psychiatric conditions account for the majority of co-occurring presentations in outpatient addiction populations: major depressive disorder, PTSD, generalized anxiety disorder, bipolar spectrum disorder, and adult ADHD. RECO screens all five at intake using validated instruments — PHQ-9 for depression, PCL-5 for PTSD, GAD-7 for anxiety, MDQ for bipolar spectrum symptoms, and ASRS for ADHD — alongside CIWA-Ar and COWS for withdrawal severity where clinically relevant, and YBOCS when comorbid OCD is suspected.

Each diagnosis has a defined evidence-based pathway inside the program. Depression is treated with an SSRI or SNRI paired with cognitive behavioral therapy or behavioral activation, escalating to bupropion augmentation, rTMS, or ketamine in treatment-resistant cases. PTSD is addressed with cognitive processing therapy, prolonged exposure, or EMDR, sequenced after stabilization. Bipolar disorder is managed with lithium or an atypical antipsychotic such as quetiapine or aripiprazole, with stimulants avoided during mood destabilization. ADHD is treated with a non-stimulant like atomoxetine or bupropion, or a carefully monitored stimulant once a period of stable abstinence has been established and diversion risk has been assessed.

MAT and psychotropic medication managed by one psychiatrist

Medication for addiction treatment and psychiatric medication are not separate conversations at RECO Health. The same in-house addiction psychiatrist who prescribes buprenorphine or extended-release naltrexone for opioid use disorder — or naltrexone and acamprosate for alcohol use disorder — also manages the client’s antidepressant, mood stabilizer, ADHD medication, or antipsychotic. Drug-drug interactions, QTc considerations, and dose timing are handled by a single clinician looking at the whole prescription list.

Fragmented prescribing is one of the most common relapse pathways in outpatient care. A primary care physician prescribes an SSRI, an outside psychiatrist adds a benzodiazepine for anxiety, and a separate MAT provider starts buprenorphine — none of them in contact, and the client left to reconcile conflicting instructions. RECO’s integrated model closes that gap. For clients whose depression proves treatment-resistant to standard pharmacotherapy, in-house rTMS — a course of 36 sessions delivering roughly 3,000 pulses per session at 120% of motor threshold to the left dorsolateral prefrontal cortex — and IV ketamine or intranasal esketamine are available as escalation options managed by the same team.

Trauma is often the through-line

For a substantial share of dual diagnosis clients, unprocessed trauma is upstream of both the substance use and the mood disorder. Alcohol suppresses intrusive memories and hyperarousal short-term; opioids blunt the affective load of shame and grief; stimulants override the anergic flatness of complex PTSD. Treat the substance use in isolation and the trauma symptoms return with force in early sobriety, driving relapse.

RECO screens for trauma at intake with the PCL-5 and a clinical interview, stabilizes during the first weeks with grounding skills, DBT distress tolerance work, and — where indicated — prazosin for trauma-related nightmares. Once the client’s window of tolerance can support processing work, therapists move into cognitive processing therapy, prolonged exposure, or EMDR. The sequencing matters: exposure work delivered too early destabilizes; delivered too late leaves the client vulnerable to relapse driven by material that was never addressed.

What to expect on your first visit

Admissions begins with a phone call to RECO’s team, a benefits verification, and a scheduled biopsychosocial assessment. The assessment itself runs 60 to 90 minutes and follows the six ASAM Criteria dimensions: acute intoxication and withdrawal risk, biomedical status, emotional and cognitive conditions, readiness to change, relapse potential, and recovery environment. Screening includes PHQ-9, GAD-7, PCL-5, MDQ, and ASRS, plus CIWA-Ar or COWS for clients with alcohol or opioid use in the prior 72 hours.

Level of care is determined the same day. Clients whose withdrawal severity or medical acuity warrants inpatient stabilization are admitted to medical detox on the Delray Beach campus. Clients who are stable enough for outpatient are placed in PHP (typically five days a week, six hours a day) or IOP (three days a week, three hours a day), with a treatment plan that names each diagnosis, each modality, and each medication, and identifies the clinician responsible for each.

Insurance and admissions from Lantana

RECO Health is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and most Blue Cross Blue Shield plans. Verification of benefits is typically completed within one business day, often within an hour for major commercial plans, and includes an out-of-pocket estimate at each level of care. From a Lantana address, the drive to the Delray Beach campus is 11 miles down Federal Highway or A1A — 18 minutes in typical Palm Beach County traffic, less at off-peak hours.

For clients whose clinical presentation makes daily commuting impractical — active withdrawal recovery, severe depression, or significant medication changes — RECO offers associated residential housing during the outpatient phase, which admissions coordinators discuss at intake based on clinical need and insurance coverage.

Serving residents of: Hypoluxo Island, Manalapan, Ocean Ridge, Old Town Lantana.